{"created":"2023-07-27T06:28:52.484891+00:00","id":13457,"links":{},"metadata":{"_buckets":{"deposit":"1f221a31-1225-44d8-bff3-e7893e3e8d1b"},"_deposit":{"created_by":3,"id":"13457","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"13457"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00013457","sets":["1132:1133:1134"]},"author_link":["22107","342","438","389","21334","22106","265","477","1206","539","22104","333","22103","22105"],"item_4_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2011-07-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"170","bibliographicPageStart":"165","bibliographicVolumeNumber":"217","bibliographic_titles":[{"bibliographic_title":"Atherosclerosis 217 (1), pp. 165-170"}]}]},"item_4_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Background: Bezafibrate and fenofibrate show different binding properties against peroxisome proliferator-activated receptor subtypes, which could cause different clinical effects on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) levels and on various metabolic markers. Methods: An open, randomized, four-phased crossover study using 400 mg of bezafibrate or 200 mg of fenofibrate was performed. Study subjects were 14 dyslipidemia with impaired glucose tolerance or type 2 diabetes mellitus (61 ± 16 years, body mass index (BMI) 26 ± 3 kg/m2, total cholesterol (TC) 219 ± 53 mg/dL, triglyceride (TG) 183 ± 83 mg/dL, high-density lipoprotein-cholesterol (HDL-C) 46 ± 8 mg/dL, fasting plasma glucose 133 ± 31 mg/dL and HbA1c 6.2 ± 0.8%). Subjects were given either bezafibrate or fenofibrate for 8 weeks, discontinued for 4 weeks and then switched to the other fibrate for 8 weeks. Circulating PCSK9 levels and other metabolic parameters, including adiponectin, leptin and urine 8-hydroxy-2′-deoxyguanosine (8-OHdG) were measured at 0, 8, 12 and 20 weeks. Results: Plasma PCSK9 concentrations were significantly increased (+39.7% for bezafibrate and +66.8% for fenofibrate, p < 0.001) in all patients except for one subject when treated with bezafibrate. Both bezafibrate and fenofibrate caused reductions in TG (-38.3%, p < 0.001 vs. -32.9%, p < 0.01) and increases in HDL-C (+18.0%, p < 0.001 vs. +11.7%, p < 0.001). Fenofibrate significantly reduced serum cholesterol levels (TC, -11.2%, p < 0.01; non-HDL-C, -17.3%, p < 0.01; apolipoprotein B, -15.1%, p < 0.01), whereas bezafibrate significantly improved glucose tolerance (insulin, -17.0%, p < 0.05) and metabolic markers (γ-GTP, -38.9%, p < 0.01; adiponectin, +15.4%, p < 0.05; urine 8-OHdG/Cre, -9.5%, p < 0.05). Conclusion: Both bezafibrate and fenofibrate increased plasma PCSK9 concentrations. The addition of a PCSK9 inhibitor to each fibrate therapy may achieve beneficial cholesterol lowering along with desirable effects of respective fibrates. © 2011 Elsevier Ireland Ltd. All rights reserved.","subitem_description_type":"Abstract"}]},"item_4_description_5":{"attribute_name":"提供者所属","attribute_value_mlt":[{"subitem_description":"金沢大学医学系研究科","subitem_description_type":"Other"}]},"item_4_publisher_17":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Elsevier Ireland Ltd"}]},"item_4_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1016/j.atherosclerosis.2011.02.012","subitem_relation_type_select":"DOI"}}]},"item_4_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://www.elsevier.com/locate/issn/00219150","subitem_relation_type_select":"URI"}}]},"item_4_source_id_11":{"attribute_name":"NCID","attribute_value_mlt":[{"subitem_source_identifier":"AA00553457","subitem_source_identifier_type":"NCID"}]},"item_4_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0021-9150","subitem_source_identifier_type":"ISSN"}]},"item_4_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Noguchi, Tohru"}],"nameIdentifiers":[{"nameIdentifier":"21334","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"40456421","nameIdentifierScheme":"研究者番号","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000040456421"}]},{"creatorNames":[{"creatorName":"Kobayashi, Junji"}],"nameIdentifiers":[{"nameIdentifier":"477","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"60302577","nameIdentifierScheme":"e-Rad","nameIdentifierURI":"https://kaken.nii.ac.jp/ja/search/?qm=60302577"},{"nameIdentifier":"60302577","nameIdentifierScheme":"研究者番号","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000060302577"}]},{"creatorNames":[{"creatorName":"Yagi, Kunimasa"}],"nameIdentifiers":[{"nameIdentifier":"438","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"30293343","nameIdentifierScheme":"e-Rad","nameIdentifierURI":"https://kaken.nii.ac.jp/ja/search/?qm=30293343"},{"nameIdentifier":"30293343","nameIdentifierScheme":"金沢大学研究者情報","nameIdentifierURI":"http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=30293343"},{"nameIdentifier":"30293343","nameIdentifierScheme":"研究者番号","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000030293343"}]},{"creatorNames":[{"creatorName":"Nohara, Atsushi"}],"nameIdentifiers":[{"nameIdentifier":"342","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"50313648","nameIdentifierScheme":"e-Rad","nameIdentifierURI":"https://kaken.nii.ac.jp/ja/search/?qm=50313648"},{"nameIdentifier":"50313648","nameIdentifierScheme":"金沢大学研究者情報","nameIdentifierURI":"http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=50313648"},{"nameIdentifier":"50313648","nameIdentifierScheme":"研究者番号","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000050313648"}]},{"creatorNames":[{"creatorName":"Yamaaki, Naoto"}],"nameIdentifiers":[{"nameIdentifier":"22103","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Sugihara, Masako"}],"nameIdentifiers":[{"nameIdentifier":"22104","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ito, Naoko"}],"nameIdentifiers":[{"nameIdentifier":"1206","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"46182858","nameIdentifierScheme":"金沢大学研究者情報","nameIdentifierURI":"http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=46182858"},{"nameIdentifier":"46182858","nameIdentifierScheme":"研究者番号","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000046182858"}]},{"creatorNames":[{"creatorName":"Oka, Rie"}],"nameIdentifiers":[{"nameIdentifier":"22105","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kawashiri, Masaaki"}],"nameIdentifiers":[{"nameIdentifier":"333","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"90345637","nameIdentifierScheme":"e-Rad","nameIdentifierURI":"https://kaken.nii.ac.jp/ja/search/?qm=90345637"},{"nameIdentifier":"90345637","nameIdentifierScheme":"金沢大学研究者情報","nameIdentifierURI":"http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=90345637"},{"nameIdentifier":"90345637","nameIdentifierScheme":"研究者番号","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000090345637"}]},{"creatorNames":[{"creatorName":"Tada, Hayato"}],"nameIdentifiers":[{"nameIdentifier":"22106","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Takata, Mutsuko"}],"nameIdentifiers":[{"nameIdentifier":"22107","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Inazu, Akihiro"}],"nameIdentifiers":[{"nameIdentifier":"539","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"80293348","nameIdentifierScheme":"e-Rad","nameIdentifierURI":"https://kaken.nii.ac.jp/ja/search/?qm=80293348"},{"nameIdentifier":"80293348","nameIdentifierScheme":"金沢大学研究者情報","nameIdentifierURI":"http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=80293348"},{"nameIdentifier":"80293348","nameIdentifierScheme":"研究者番号","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000080293348"}]},{"creatorNames":[{"creatorName":"Yamagishi, Masakazu"}],"nameIdentifiers":[{"nameIdentifier":"265","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"70393238","nameIdentifierScheme":"e-Rad","nameIdentifierURI":"https://kaken.nii.ac.jp/ja/search/?qm=70393238"},{"nameIdentifier":"70393238","nameIdentifierScheme":"金沢大学研究者情報","nameIdentifierURI":"http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=70393238"},{"nameIdentifier":"70393238","nameIdentifierScheme":"研究者番号","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000070393238"}]},{"creatorNames":[{"creatorName":"Mabuchi, Hiroshi"}],"nameIdentifiers":[{"nameIdentifier":"389","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"00019960","nameIdentifierScheme":"e-Rad","nameIdentifierURI":"https://kaken.nii.ac.jp/ja/search/?qm=00019960"},{"nameIdentifier":"00019960","nameIdentifierScheme":"研究者番号","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000000019960"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-10-03"}],"displaytype":"detail","filename":"ME-PR-KOBAYASHI-J-165","filesize":[{"value":"167.4 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/octet-stream","url":{"label":"ME-PR-KOBAYASHI-J-165","url":"https://kanazawa-u.repo.nii.ac.jp/record/13457/files/ME-PR-KOBAYASHI-J-165"},"version_id":"46ecd0bd-c405-4465-8c5c-66808fdeb38c"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: Results from a crossover study","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: Results from a crossover study"}]},"item_type_id":"4","owner":"3","path":["1134"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-10-03"},"publish_date":"2017-10-03","publish_status":"0","recid":"13457","relation_version_is_last":true,"title":["Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: Results from a crossover study"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2024-06-20T07:19:43.432815+00:00"}